← Leaderboards
Shibani Mukerji
Case Western Reserve University
$5,492,935
Attributed
$6,679,700
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,679,700 · 4
By mechanism
R01$5,667,036 · 2
K23$925,500 · 1
F30$87,164 · 1
Top collaborators
- Xu Yu3 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Jaclene A Zauszniewski$7,130,804
- Valerie Annette Toly$2,681,053
- Carol M Musil$5,327,479
- Carolyn Harmon Still$5,253,566
- Anton Vehovec$87,620
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainCellsPositioning AttributeImmuneBloodAffectResearch PersonnelInsightFunctional DisorderPathogenesisGenesMental DepressionDepressive SymptomsMediatingCorpus Striatum StructureInfrastructureCohortPersonsNeuroimagingResponseAntiretroviral TherapyBiologicalDisabilityChronic
Grant awards (16)
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.$709,667
R01 · FY2025 · MH · contact PI
Characterizing HIV-1 reservoirs in the central nervous system$707,024
R01 · FY2025 · MH
Characterizing HIV-1 reservoirs in the central nervous system$831,792
R01 · FY2024 · MH
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.$755,637
R01 · FY2024 · MH · contact PI
Characterizing HIV-1 reservoirs in the central nervous system$834,714
R01 · FY2023 · MH
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.$755,854
R01 · FY2023 · MH · contact PI
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.$249,723
R01 · FY2023 · MH · contact PI
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.$822,625
R01 · FY2022 · MH · contact PI
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-Infection$185,220
K23 · FY2022 · MH · contact PI
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-Infection$185,220
K23 · FY2021 · MH · contact PI
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-Infection$185,020
K23 · FY2020 · MH · contact PI
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-Infection$185,020
K23 · FY2019 · MH · contact PI
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-Infection$185,020
K23 · FY2018 · MH · contact PI
Activin in cerebral hypoxia and acute focal ischemia$27,367
F30 · FY2009 · NS · contact PI
Activin in cerebral hypoxia and acute focal ischemia$27,103
F30 · FY2008 · NS · contact PI
Activin in cerebral hypoxia and acute focal ischemia$32,694
F30 · FY2007 · NS · contact PI